PROS1 and acute myeloid leukemia: BCL-2 is an anti-apoptotic protein involved in mitochondrial outer membrane integrity, and its inhibition by venetoclax serves as a therapeutic option in chronic lymphocytic leukaemia, acute myeloid leukaemia, and other diseases.